Trial NCT04543916

View at ClinicalTrials.gov 
Org. Study IDs: MCC-17-13842
Secondary IDs: HM20019851

Last trial update was posted on 2021-03-03

MeSH Interventions

Irinotecan Venetoclax

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Refractory Small Cell Lung Carcinoma Relapsed Small Cell Lung Cancer

Stopping Reasons

AbbVie decided to stop trial involving Venetoclax for safety measures needed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID